Literature DB >> 30145975

[How to diagnose heart-failure?]

Yu-Ching Liu1, Otmar Pfister1.   

Abstract

How to diagnose heart failure? Abstract. In light of the ongoing demographic development with a continuous increase in people older than 65 years heart failure becomes a growing public health issue. The suspicion of the diagnosis is based on clinical signs and symptoms representing the effects of increased cardiac filling pressure, congestion and hypoperfusion. Natriuretic peptides (BNP and NT-proBNP) are key to corroborate the working diagnosis. In subjects with natriuretic peptide levels above the threshold of exclusion, the diagnosis is confirmed by documenting the underlying functional or structural cardiac alterations using echocardiography.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30145975     DOI: 10.1024/0040-5930/a000982

Source DB:  PubMed          Journal:  Ther Umsch        ISSN: 0040-5930


  3 in total

1.  Efficacy of ivabradine for heart failure: A protocol for a systematic review of randomized controlled trial.

Authors:  En-Zhong Xue; Ming-Hui Zhang; Chun-Li Liu
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

2.  The Effect of Ivabradine on Hospitalization of Heart Failure Patients: A Retrospective Cohort Study.

Authors:  Sara Al-Balushi; Mohammed Fasihul Alam; Abdul Rehman Abid; Amal Sharfi
Journal:  Heart Views       Date:  2021-10-11

3.  Levels of Serum IGF-1, HCY, and Plasma BNP in Patients with Chronic Congestive Heart Failure and Their Relationship with Cardiac Function and Short-Term Prognosis.

Authors:  Zhengyi Hu; Leifang Mao; Ling Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-23       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.